Aims Much controversy exists concerning the efficacy of primary prophylactic implantable
cardioverter-defibrillators (ICDs) in patients with low ejection fraction due to coronary artery …

Abstract Aims The EUropean Comparative Effectiveness Research to Assess the Use of
Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective …

Background: Implantable cardioverter-defibrillators (ICDs) have a role in preventing cardiac
arrest in patients at risk for life-threatening ventricular arrhythmias. Purpose: To compare …

Implantable cardioverter-defibrillator (ICD) is the standard of care for prevention of sudden
cardiac death (SCD) in high-risk patients. For primary prevention of SCD, in patients with …

Background Sudden cardiac death (SCD) is frequent in patients with heart failure due to
dilated cardiomyopathy (DCM). Implantable cardioverter/defibrillator (ICD) device therapy is …

Importance Conflicting data have emerged on the efficacy of implantable cardioverter
defibrillators (ICDs) for primary prevention of sudden cardiac death (primary prevention …

Background: Most randomized trials on implantable cardioverter-defibrillator (ICD) use for
primary prevention of sudden cardiac death in heart failure with reduced ejection fraction …

ContextSudden cardiac death (SCD) is a major challenge facing contemporary cardiology.
For an increasing number of patients, the current standard of care for the treatment and …

Background: Patients with nonischemic dilated cardiomyopathy (DCM) may be at lower risk
for ventricular arrhythmias compared with those with ischemic cardiomyopathy (ICM). In …

This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Background: Implantable cardioverter-defibrillators (ICDs) for the primary …